Rocuronium
***RSI Drug***
***RSI Drug***
Rocuronium
***RSI Drug***
Class: neuromuscular blockade NON-depolarizing, ***RSI drug***
Action: Antagonizes acetylcholine at the motor end plate producing skeletal muscle paralysis.
Indications: To induce neuromuscular blockage for the facilitation of advanced airway / ET tube placement.
Adverse Effects: muscle paralysis, apnea, dyspnea, respiratory depression, sinus tachycardia urticaria, hypertension
Contraindications: Known sensitivity to bromides. Use caution in heart and liver disease patients.
Special Considerations: Pregnancy Class B
Dosages:
Adults:
Paralysis:
1mg/kg IV/IO
Re-paralysis:
0.6mg/kg IV/IO
Pediatrics:
NONE